ROYAL BANK OF CANADA - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 55 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$02,5040.0%0.00%
Q4 2018$0
-100.0%
2,5040.0%0.00%
Q3 2018$1,0000.0%2,5040.0%0.00%
Q2 2018$1,0000.0%2,504
-3.8%
0.00%
Q1 2018$1,000
-50.0%
2,604
-61.2%
0.00%
Q4 2017$2,000
-50.0%
6,704
-37.4%
0.00%
Q3 2017$4,000
-20.0%
10,704
+0.8%
0.00%
Q2 2017$5,000
-16.7%
10,623
+0.2%
0.00%
Q1 2017$6,000
-14.3%
10,6000.0%0.00%
Q4 2016$7,000
-30.0%
10,6000.0%0.00%
Q3 2016$10,000
+66.7%
10,6000.0%0.00%
Q2 2016$6,000
-40.0%
10,6000.0%0.00%
Q1 2016$10,000
-91.5%
10,600
-88.0%
0.00%
Q4 2015$118,000
+195.0%
88,345
+400.8%
0.00%
Q3 2015$40,000
+25.0%
17,642
-10.2%
0.00%
Q2 2015$32,000
+6.7%
19,651
+3.2%
0.00%
Q1 2015$30,000
+50.0%
19,039
+79.6%
0.00%
Q4 2014$20,000
+81.8%
10,600
+23.3%
0.00%
Q3 2014$11,000
-15.4%
8,600
-2.3%
0.00%
Q2 2014$13,000
-64.9%
8,800
-55.6%
0.00%
Q1 2014$37,000
+117.6%
19,823
+141.7%
0.00%
Q4 2013$17,000
-93.3%
8,200
-91.5%
0.00%
Q3 2013$255,000
+507.1%
96,269
+509.0%
0.00%
Q2 2013$42,00015,8070.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2018
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders